Anna Mariola Żdanowicz

Dr. Anna Mariola Żdanowicz

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AŻAnna Mariola Żdanowicz
Anna Mariola Żdanowicz
HSHanna Sobkowiak
Hanna Sobkowiak
MGMaciej Gawrysiak
Maciej Gawrysiak
MWMałgorzata Wiszniewska
Małgorzata Wiszniewska
Background/Objectives: Management of the acute phase of ischemic stroke requires intensive interdisciplinary collaboration among medical personnel. Dysphagia, or swallowing disorders, represents a serious complication of stroke. Accurate diagnosis and identification of the causes of dysphagia are essential for implementing effective treatment. The aim of the study was to investigate the impact of age, acute stroke treatment, localization, comorbidities, and early rehabilitation on the severity and progression of dysphagia in patients with acute ischemic stroke. Methods: The study analyzed the severity and progression of dysphagia in patients with ischemic stroke, considering patient age, stroke localization, comorbidities, and the impact of thrombolytic therapy and early rehabilitation on swallowing outcomes. Results: Severe dysphagia was more common among older patients and those with cardiovascular conditions. Early rehabilitation was particularly effective in improving swallowing in right hemisphere strokes, while thrombolytic therapy demonstrated benefits for patients under 65 years. Conclusions: Therapy led to an improvement in the condition of all patients with dysphagia following ischemic stroke. Further prospective research is needed to better understand swallowing disorders and optimize treatment.

29 December 2022 in The Journal of Neurological and Neurosurgical Nursing
Verified
Journal Article
Open access
PDF file
AŻAnna Mariola Żdanowicz
Anna Mariola Żdanowicz
JJJulia Jaszczyk
Julia Jaszczyk
SPSabina Płociennik
Sabina Płociennik
NŁNatalia Łyszyk
Natalia Łyszyk
MWMałgorzata Wiszniewska
Małgorzata Wiszniewska
Wstęp. Udar mózgu jest to nagły, niespodziewany stan, który może zagrażać życiu i konieczna jest hospitalizacja. Bardzo ważny jest czas od momentu pojawienia się objawów udaru do udzielenia pomocy medycznej. Im później zostanie udzielona pomoc tym szanse na odzyskanie sprawności maleją, a wzrasta możliwość wystąpienia trwałej niesprawności. Cel. Celem pracy była ocena poziomu wiedzy studentów kierunków medycznych i niemedycznych na temat zasad udzielania pierwszej pomocy przedmedycznej w udarze mózgu oraz określenie stanu ogólnej wiedzy na temat udaru mózgu. Materiał i metody. Badanie przeprowadzono wśród studentów Akademii Nauk Stosowanych im. Stanisława Staszica w Pile w roku akademickim 2020/2021. W badaniu wzięło udział 186 studentów, w tym 77 studentów kierunków niemedycznych i 109 studentów kierunków medycznych. W pracy posłużono się metodą sondażu diagnostycznego posługując się autorską ankietą. Każdą daną opisano w ujęciu ilościowo-procentowym. Rozkład cech w grupach studentów kierunków niemedycznych i medycznych sprawdzono testem chi-kwadrat. Za poziom istotności przyjęto p < 0,05. Wyniki. Poziom wiedzy studentów uzależniony był od kierunku studiów. Studenci kierunków niemedycznych zdecydowanie częściej udzielali odpowiedzi „nie wiem” na zadawane pytania, mieli mniejszą wiedzę na temat rozpoznawania objawów czy czynników ryzyka udaru mózgu. Średni poziom wiedzy studentów kierunków niemedycznych wynosił 2,88 ± 0,79 i był istotnie niższy (t = –5,73, p < 0,0001) od średniego poziomu wiedzy studentów kierunków medycznych 3,60 ± 0,97. Wnioski. Słabsza znajomość problematyki związanej z udarem mózgu wśród studentów kierunków niemedycznych wskazuje na konieczność pilnej edukacji studentów w zakresie udaru, aby umieli rozpoznać udar mózgu i podjęli szybko właściwe działania, dzięki którym pacjent będzie miał szanse na szybkie dotarcie do właściwego szpitala, a tym samym otrzyma jak najlepsze leczenie według obowiązujących zaleceń. Studenci studiów zarówno medycznych, jak i niemedycznych powinni mieć możliwość uczestnictwa w dodatkowych zajęciach kształcących wiedzę oraz umiejętności praktyczne z zakresu postępowania w udarze mózgu. (PNN 2022;11(4):154–161)

10 May 2024 in Neurology International
Verified
Journal Article
Open access
PDF file
MWMałgorzata Wiszniewska
Małgorzata Wiszniewska
UWUrszula Włodarczyk
Urszula Włodarczyk
MSMagdalena Sury
Magdalena Sury
Artur SłomkaArtur Słomka
Artur Słomka
NPNatalia Piekuś-Słomka
Natalia Piekuś-Słomka
EŻEwa Żekanowska
Ewa Żekanowska
Background and Aims: In recent years, there has been a growing interest in factor XIII in ischaemic stroke. The study’s main aim was to assess the usefulness of factor XIII concentration determination in patients with acute ischaemic stroke (AIS) treated with thrombolysis with recombinant tissue plasminogen activator (t-PA). Methods: The study was conducted in two groups of 84 patients with AIS: group I—with thrombolytic therapy and group II—without thrombolysis. A physical examination, neurological status (using the National Institutes of Health Stroke Scale, NIHSS), daily patients’ activities measured with the Barthel Index and Modified Rankin Scale (mRS), and blood parameters were conducted on day 1 and day 7. The following parameters were assessed: highly sensitive C-reaction protein (CRP), fibrinogen, D-dimers (DD), neutrophil–lymphocyte ratio (NLR index), and the concentration of factor XIII-A. Results: In group I, the concentration of XIII-A decreased significantly between day 1 and 7 (p < 0.001). In group I, the concentration of XIII-A on day 7 in Total Anterior Circulation Infarct (TACI) was significantly lower than in non-TACI stroke. XIII-A concentration in group I was significantly lower in patients < 31 points with Acute Stroke Registry and Analysis of Lausanne (ASTRAL). A greater decrease in XIII-A between the first sampling on day 1 and the second sampling on day 7 was associated with a worse patient neurological state in group I. Conclusions: In patients with AIS treated with t-PA, factor XIII concentrations decrease in the acute phase of stroke, and the largest decrease occurs in the TACI stroke. Determination of factor XIII concentration in patients with AIS can be used in clinical practice as an additional parameter supporting the assessment of stroke severity and may play a role in the prognosis; lower factor XIII-A activity may be a predictor of a worse prognosis.

31 March 2026 in The Journal of Neurological and Neurosurgical Nursing
Verified
Journal Article
Open access
PDF file
MWMałgorzata Wiszniewska
Małgorzata Wiszniewska
MGMaciej Gawrysiak
Maciej Gawrysiak
AŻAnna Mariola Żdanowicz
Anna Mariola Żdanowicz
Introduction. Dysphagia, a serious complication of stroke, requires precise diagnosis and interdisciplinary treatment, including dietary modifications. Aim. The aim of this study is to present a case of a patient with cerebellar stroke and dysphagia, highlighting the effectiveness of comprehensive treatment and rehabilitation in restoring swallowing function and oral feeding. Case Report. A retrospective analysis of medical records was conducted to evaluate diagnostic and therapeutic interventions. The study presents a case of a patient hospitalized in the Neurology Department of Stanisław Staszic Specialist Hospital in Piła with a diagnosis of cerebellar ischemic stroke, in whom dysphagia was an early and significant complication. Due to swallowing difficulties the patient initially required feeding via a nasogastric tube. Swallowing function was assessed on the first, eighth, and ninth days of hospitalization using the Gugging Swallowing Screen (GUSS) test, a simple and easy-to-administer screening tool. By the eighth day of hospitalization, the patient demonstrated sufficient improvement in swallowing function to initiate oral intake of fluids, which was well tolerated. From the ninth day, the patient was able to consume foods of varying consistencies, as confirmed by a structured swallowing assessment. These improvements were achieved through targeted rehabilitation conducted by a speech therapist and supported by nursing staff. Clinical progress led to the removal of the nasogastric tube on the tenth day, indicating substantial advancement in the patient’s recovery. Discussion. Post-stroke dysphagia is a serious medical condition that can be effectively managed through interdisciplinary rehabilitation. Complications such as aspiration pneumonia and impaired nutritional status are widely recognized risks among patients with dysphagia. Conclusions. This case illustrates how early diagnosis using simple methods and a comprehensive treatment approach can improve vital functions and enhance the quality of life in stroke patients. (JNNN 2026;15(1):21–28)

6 February 2026 in Neurology International
Verified
Journal Article
Open access
PDF file
MWMałgorzata Wiszniewska
Małgorzata Wiszniewska
UWUrszula Włodarczyk
Urszula Włodarczyk
MDMariusz Domagalski
Mariusz Domagalski
Artur SłomkaArtur Słomka
Artur Słomka
IDInga Dziembowska
Inga Dziembowska
EŻEwa Żekanowska
Ewa Żekanowska
Background/Objectives: Protein Z (PZ) and the protein Z-dependent protease inhibitor (ZPI) are vitamin K-dependent regulators of coagulation that inhibit activated factor Xa. Their relevance in ischemic stroke (IS) remains insufficiently characterized, with inconsistent evidence regarding their association with stroke severity and outcomes. This study aimed to evaluate the concentrations and dynamics of PZ and ZPI in the acute phase of IS in patients treated with intravenous thrombolysis or conservative therapy and to assess their potential prognostic significance. Methods: Eighty-four patients with acute IS were enrolled and divided into two groups: group I treated with intravenous thrombolysis (rt-PA) and group II managed conservatively. PZ and ZPI concentrations were measured using ELISA on admission (day 1) and on day 7. Associations with factor X activity, the modified Rankin Scale (mRS), and the National Institutes of Health Stroke Scale (NIHSS) were analyzed using nonparametric tests and Spearman correlations (p < 0.05). Results: PZ concentrations were significantly higher in thrombolysis-treated patients than in conservatively managed patients both on day 1 (median: 2810.05 vs. 2178.50 ng/mL; p = 0.024) and day 7 (2982.90 vs. 2286.50 ng/mL; p = 0.026). A slight negative correlation between PZ and mRS on day 7 was observed in the conservative group (r = −0.360; p = 0.043). In thrombolysis-treated patients with dyslipidemia, PZ increased from day 1 to day 7, whereas it decreased in those without dyslipidemia. No significant correlations were found between PZ, ZPI, or factor X and NIHSS or ASTRAL scores. Conclusions: Higher PZ concentrations in the acute phase of IS—particularly in rt-PA-treated patients—may reflect differences related to the timing of the acute ischemic process and reperfusion status, suggesting potential utility as markers of stroke severity or outcome.